Evidence map›Paper›PMID 26442912›Full record

ArticleJournal of biomolecular screening2016

Understanding ForteBio's Sensors for High-Throughput Kinetic and Epitope Screening for Purified Antibodies and Yeast Culture Supernatant.

Yao Yu, Scott Mitchell, Heather Lynaugh, Michael Brown, R Paul Nobrega, Xiaoyong Zhi, Tingwan Sun, Isabelle Caffry, Yuan Cao, Rong Yang and 3 more

Abstract read
In one paragraph

Article in Journal of biomolecular screening, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yao YuProtein Analytics, Adimab, LLC, Lebanon, NH, USA.
Scott MitchellThayer School of Engineering, Dartmouth College, Hanover, NH, USA.
Heather LynaughProtein Analytics, Adimab, LLC, Lebanon, NH, USA.
Michael BrownProtein Analytics, Adimab, LLC, Lebanon, NH, USA.
R Paul NobregaProtein Analytics, Adimab, LLC, Lebanon, NH, USA.
Xiaoyong ZhiProtein Analytics, Adimab, LLC, Lebanon, NH, USA.
Tingwan SunProtein Analytics, Adimab, LLC, Lebanon, NH, USA.
Isabelle CaffryProtein Analytics, Adimab, LLC, Lebanon, NH, USA.
Yuan CaoProtein Analytics, Adimab, LLC, Lebanon, NH, USA.
Rong YangProtein Analytics, Adimab, LLC, Lebanon, NH, USA.
Irina BurninaProtein Analytics, Adimab, LLC, Lebanon, NH, USA.
Yingda XuProtein Analytics, Adimab, LLC, Lebanon, NH, USA.
Patricia EstepProtein Analytics, Adimab, LLC, Lebanon, NH, USA patricia.estep@adimab.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Real-time and label-free antibody screening systems are becoming more popular because of the increasing output of purified antibodies and antibody supernatant from many antibody discovery platforms. However, the properties of the biosensor can greatly affect the kinetic and epitope binning results generated by these label-free screening systems. ForteBio human-specific ProA, anti-human IgG quantitation (AHQ), anti-human Fc capture (AHC) sensors, and custom biotinylated-anti-human Fc capture (b-AHFc) sensors were evaluated in terms of loading ability, regeneration, kinetic characterization, and epitope binning with both purified IgG and IgG supernatant. AHC sensors proved unreliable for kinetic or binning assays at times, whereas AHQ sensors showed poor loading and regeneration abilities. ProA sensors worked well with both purified IgG and IgG supernatant. However, the interaction between ProA sensors and the Fab region of the IgG with VH3 germline limited the application of ProA sensors, especially in the epitope binning experiment. In an attempt to generate a biosensor type that would be compatible with a variety of germlines and sample types, we found that the custom b-AHFc sensors appeared to be robust working with both purified IgG and IgG supernatant, with little evidence of sensor-related artifacts.

Indexed as

Antibodies, MonoclonalBiological AssayBiosensing TechniquesBiotinylationEpitopesHumansImmunoglobulin GKineticsYeastsAntibodies, MonoclonalEpitopesImmunoglobulin Gepitope binninghigh-throughput screeningkineticsupernatant

Identifiers

PMID26442912
PMCPMC4708621

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.